Long-Term Outcomes of Parenteral Prostacyclin Use in Adults With Congenital Heart Disease–Associated Pulmonary Hypertension
Heart, Lung and Circulation · 2026-11
DOI: 10.1016/j.hlc.2026.06.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Heart, Lung and Circulation, 2026-11. Verfasst von Brandon R. Jakubowski und 9 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Gefördert von: National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Center for Advancing Translational Sciences
Zitieren
APA
Jakubowski, B. R., Sande-Docor, G., Kentros, P. A., Rosa, I. I. D. L., Berrio, M. A. O., Kearney, K., Tan, W., Shah, T., Bartolome, S., & Chin, K. S. (2026). Long-Term Outcomes of Parenteral Prostacyclin Use in Adults With Congenital Heart Disease–Associated Pulmonary Hypertension. Heart, Lung and Circulation. https://doi.org/10.1016/j.hlc.2026.06.014
Vancouver
Jakubowski BR, Sande-Docor G, Kentros PA, Rosa IIDL, Berrio MAO, Kearney K, et al. Long-Term Outcomes of Parenteral Prostacyclin Use in Adults With Congenital Heart Disease–Associated Pulmonary Hypertension. Heart, Lung and Circulation. 2026. doi:10.1016/j.hlc.2026.06.014
BibTeX
@article{Jakubowski2026,
author = {Jakubowski, Brandon R. and Sande-Docor, Glaiza and Kentros, Peter A. and Rosa, Iris I. De La and Berrio, Maira A. Ortiz and Kearney, Katherine and Tan, Weiyi and Shah, Trushil and Bartolome, Sonja and Chin, Kelly S.},
title = {Long-Term Outcomes of Parenteral Prostacyclin Use in Adults With Congenital Heart Disease–Associated Pulmonary Hypertension},
journal = {Heart, Lung and Circulation},
year = {2026},
doi = {10.1016/j.hlc.2026.06.014}
}
EUVIMED